Chronische lymphatische Leukämie

  • B. Emmerich

Zusammenfassung

Die chronische lymphatische Leukämie (CLL) ist ein stets leukämisch verlaufendes, lymphozytisches Non-Hodgkin-Lymphom vom niedrigen Malignitätsgrad.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Cooperative Group for the Study of Immunoglobulin in Chronic Lymphocytic Leukemia (1988) Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia. A randomized controlled clinical trial. N Engl J Med 319: 902–907CrossRefGoogle Scholar
  2. Dillman RO, Mick R, McIntyre OR (1989) Pentostatin in chronic lymphocytic leukemia: A Phase II trial of Cancer and Leukemia Group. Br J Clin Oncol 7: 433–438Google Scholar
  3. Döhner H, Ho AD, Thaler Jet al. (1993) Pentostatin in prolymphocytic leukemia: Phase II Trial of the European Organization for Research and Treatment of Cancer Leukemia Cooperative Study Group. J Natl Cancer Inst 85: 658–662Google Scholar
  4. Döhner H, Fischer K, Bentz M et al. (1995) p53 gene deletion predicts for poor survial and non-response to therapy with purine analogs in chronic B-cell leukemia. Blood 85: 1580–1589Google Scholar
  5. Foon KA, Gale RP (1992) Is there a T-cell form of chronic lymphocytic leukemia? Leukemia 6: 867–868PubMedGoogle Scholar
  6. Foon KA, Rai KR, Gale RP (1990) Chronic lymphocytic leukemia. New insights into biology and therapy. Ann Intern Med 113: 525–539Google Scholar
  7. French Cooperative Group on Chronic Lymphocytic Leukemia (1986) Effectiveness of „CHOP“ regimes in advanced untreated chronic lymphocytic leukemia. Lancet I, 1346–1349Google Scholar
  8. French Cooperative Group on chronic lymphocytic leukemia (1990) Effects of chlorambucil and therapeutic decision in initial forms of chronic lymphocytic leukemia (stage A): Results of a randomized clinical trial on 612 patients. Blood 75: 1414–1421Google Scholar
  9. Hansen MM, Andersen E, Birgens H et al. (1991) CHOP versus chlorambucil + prednisolone in chronic lymphocytic leukemia. Leuk Lymphoma 5: 97–100CrossRefGoogle Scholar
  10. Hiddemann W (1993) Chronische lymphatische Leukämie: Aktueller Stand and Pespektiven. Internist 34: 534–541PubMedGoogle Scholar
  11. Imby E, Mellstedt H (1991) Chlorambucil/prednisone versus CHOP in symptomatic chronic lymphocytic leukemias of B-cell type. A randomized trial. Leuk Lymphoma 5: 93–96Google Scholar
  12. International Workshop on Chronic Lymphocytic Leukemia (1988) Chronic lymphocytic leukemia: Recommendations for diagnosis, staging, and response criteria. Ann Intern Med 110: 236–238Google Scholar
  13. Kantarjian HM, Childs G, O’Brien S et al. (1991) Efficacy of Fludarabine, a new adenine nucleoside analogue in patients with prolymphocytic leukemia. Am J Med 90: 233–228Google Scholar
  14. Keating MJ, Scouros M, Murphy S et al. (1988) Multiple agent chemotherapy ( POACH) in previously treated and untreated patients with chronic lymphocytic leukemia. Leuk Lymphoma 2: 157–164Google Scholar
  15. Keating MJ, Kantarjian H, Talpaz M et al. (1989) Fludarabine: A new agent with major activity against chronic lymphocytic leukemia. Blood 74: 19–25Google Scholar
  16. Keating MJ, Hester JP, McCredie KB, Burgess MA, Murphy WK, Freireich EJ (1990). Long-term results of CAP therapy in chronic lymphocytic leukemia. Leuk Lymphoma 2: 391–397CrossRefGoogle Scholar
  17. Kempin S, Lee BH III, Thaler HT et al. (1982) Combination chemotherapy of advanced chronic lymphocytic leukemia. The M2-protocol (vincristine, BCNU, cyclophosphamide, melphalan and prednisone ). Blood 60: 1110–1121Google Scholar
  18. Knospe WH, Loeb V, Hugulex CM (1974) Biweekly chlorambucil treatment of chronic lymphocytic leukemia. Cancer 33: 555–562PubMedCrossRefGoogle Scholar
  19. Matutes E, Catovsky D (1993) CLL should be used only for the disease with B-cell phenotype (letter). Leukemia 7: 917–918PubMedGoogle Scholar
  20. Matutes E, Brito-Babapulle V, Swansburg J et al. (1991) Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia. Blood 78: 3269–3274PubMedGoogle Scholar
  21. Melo JV, Catovsky D, Salton DAG (1986) The relationship between chronic lymphatic leukemia and prolymphocytic leukemia. I. clinical and laboratory features of 300 patients and characterisation of an intermediate group. Br J Hematol 63: 377–387CrossRefGoogle Scholar
  22. Michallet M, Corront B, Hollard D, Gratwohl A et al. (1991) Allogeneic bone marrow transplantation in chronic lymphocytic leukemia: 17 cases. Report from the European Cooperative Group for bone marrow transplantation. Bone Marrow Transplant 7: 275–279Google Scholar
  23. Montserrat E, Alcala A, Parody R et al. (1985) Treatment of chronic lymphocytic leukemia in advanced stages: A randomized trial comparing chlorambucil plus prednisone versus cyclophosphamid, vincristine and prednisone. Cancer 56: 2369–2375Google Scholar
  24. OBrien S, del Giglio A, Keating M (1995) Advances in the Biology and Treatment of B-Cell Chronic Lymphocytic Leukemia. Blood 85: 307–318Google Scholar
  25. Piro LD, Carrera CJ, Beutler E, Carson DA (1988) Chlorodeoxyadenosine. An effective new agent for the treatment of CLL, chronic lymphatic leukemia. Blood 72: 1069–1073Google Scholar
  26. Rabinowe SN, Soiffer RJ, Gribben JG et al. (1993) Autologous and allogeneic bone marrow transplantation for poor prognosis patients with B-Cell chronic lymphocytic leukemia. Blood 82: 1366–1376PubMedGoogle Scholar
  27. Rai KR, Rabinowe SN (1993) Chronic lymphocytic leukemia. In: Holland IF, Frei E III, Bart RC et al. (eds) Cancer Medicine, vol II, 3rd edn. Lea & Febiger, Philadelphia London, pp 1971–1988Google Scholar
  28. Raphael B, Andersen JW, Silber R et al. (1991) Comparison of chlorambucil and prednisone versus cyclophosphamide, vincristine, and prednisone as initial treatment for chronic lymphocytic leukemia: Long-term follow-up of an Eastern Cooperative Oncology Group randomized clinical trial. J Clin Oncol 9: 770–776Google Scholar
  29. Rozman C, Montserrat E (1989) When and how to treat chronic lymphocytic leukemia. Blut 59: 467–474PubMedCrossRefGoogle Scholar
  30. Saven A, Carrera CJ, Carson DA, Beutler E, Piro LD (1991) 2-Chlorodeoxyadenosine treatment of refractory chronic lymphocytic leukemia. Leuk Lymphoma 5: 133–138Google Scholar
  31. Sawitsky A et al. (1977) Comparison of daily versus intermittant chlorambucil and prednisone therapy in the treatment of patients with chronic lymphocytic leukemia. Blood 50: 1049–1059PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1997

Authors and Affiliations

  • B. Emmerich

There are no affiliations available

Personalised recommendations